KOAH Atak

Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: 2020 report. Global Initiative for Chronic Obstructive Lung Disease website. https://goldcopd.org/wp-content/uploads/2019/11/GOLD-2020-REPORT-ver1.0wms.pdf Published 2019. Accessed June 12, 2020.

Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet 2007; 370(9589): 786-96.

TUİK (2018). Ölüm Nedeni İstatistikleri 2018. (13.06.2020 tarihinde http://www.tuik.gov.tr/PreHaberBultenleri.do?id=30626 adresinden ulaşılmıştır).

Arslan Z, Ilgazlı A, Etiler N, Hamzaoğlu O. Prevalence of chronic obstructive pulmonary disease in kocaeli: an industrialised city in Turkey. Balkan Med J. 2013;30(4):387-393. doi:10.5152/balkanmedj.2013.8042

Kocabaş A, Hancıoğlu A, Türkyılmaz S, Ünalan T, Umut S, et al. Prevalence of COPD in Adana, Turkey. Eur Respir J 2005; 26:804.

Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P,et al.Severe acute exacerbations and mortality inpatients with chronic obstructive pulmonary disease.Thorax2005; 60: 925–931.

Ball P. Epidemiology and treatment of chronic bronchitis and its exacerbations. Chest 1995;108:43S-52S.

Connors AF Jr, Dawson NV, Thomas C, Harrell FE Jr, Desbiens N, Fulkerson WJ, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (study to understand prognoses and preferences for outcomes and risks of treatments) Am J Respir Crit Care Med 1996;154:959-67.

Monsó E, Ruiz J, Rosell A, Manterola J, Fiz J, Morera J, et al. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 1995;152:1316-20.

Alobaidi N, Stockley J, Stockley R, Sapey E. An overview of exacerbations of chronic obstructive pulmonary disease: Can tests of small airways' function guide diagnosis and management? Annals of Thoracic Medicine. 2020;15(2):54-63.

Celli BR and Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 2007; 29: 1224-38.

Umut S. (2010). Kronik Obstrüktif Akciğer Hastalığında Atak Tedavisi. Tevfik Özlü (Ed.), Solunum Sistemi ve Hastalıkları içinde (s.719-723). İstanbul: İstanbul Tıp Kitabevi

Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196–204.

Kaya A (2008). Kronik Obstrüktif Akciğer Hastalığında Atak ve Tedavisi. Hayati Bilgiç, Mehemet Karadağ (Ed.), Tanımdan Tedaviye Kronik Obstrüktif Akciğer Hastalığı içinde (s:193-205). İstanbul: Galenos Yayınevi

Li X-J, Li Q, Si L-Y, Yuan Q-Y. Bacteriological differences between COPD exacerbation and community-acquired pneumonia. Respiratory Care. 2011;56(11):1818-24.

Wells JM, Washko GR, Han MK, et al. Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med 2012; 367(10): 913-21.

Celli BR, MacNee W, ATS ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23(6): 932-46.

van Geffen WH, Douma WR, Slebos DJ, Kerstjens HA. Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD. Cochrane Database Syst Rev 2016; (8): CD011826.

Barr RG, Rowe BH, Camargo CA, Jr. Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta- analysis of randomised trials. BMJ 2003; 327(7416): 643.

Walters JAE, Tan DJ, White CJ, Gibson PG, Wood‐Baker R, Walters EH. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews. 2014(9).

de Jong YP, Uil SM, Grotjohan HP, Postma DS, Kerstjens HA, van den Berg JW. Oral or IV prednisolone in the treatment of COPD exacerbations: a randomized, controlled, double-blind study. Chest 2007; 132(6): 1741-7.

Ram FS, Rodriguez-Roisin R, Granados-Navarrete A, Garcia-Aymerich J, Barnes NC. Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006; (2): CD004403.

Austin MA, Wills KE, Blizzard L, Walters EH, Wood-Baker R. Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial. BMJ 2010; 341: c5462.

Roca O, Hernandez G, Diaz-Lobato S, Carratala JM, Gutierrez RM, Masclans JR. Current evidence for the effectiveness of heated and humidified high flow nasal cannula supportive therapy in adult patients with respiratory failure. Crit Care 2016; 20(1): 109.

Osadnik CR, Tee VS, Carson-Chahhoud KV, Picot J, Wedzicha JA, Smith BJ. Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2017; 7: CD004104.

Plant PK, Owen JL, Elliott MW. Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial. Lancet 2000; 355(9219): 1931-5.

Chandra D, Stamm JA, Taylor B, et al. Outcomes of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease in the United States, 1998-2008. Am J Respir Crit Care Med 2012; 185(2): 152-9.